Literature DB >> 15709824

Clinical status of at-risk individuals 5 years later: further validation of the psychometric high-risk strategy.

Diane C Gooding1, Kathleen A Tallent, Christie W Matts.   

Abstract

The authors hypothesized that at-risk individuals identified on the basis of their Chapman scale scores would be diagnosed with schizophrenia-spectrum disorders at follow-up. In the present study, the authors interviewed 135 young adults approximately 5 years following their initial assessment. The at-risk groups included high scorers on the Perceptual Aberration and/or Magical Ideation Scales (n=59) and high scorers on the revised Social Anhedonia Scale (n=32). The control participants (n=44) scored below 0.5 SD of the same-sex group means on all the scales. At the follow-up, the groups differed in terms of their likelihood of having a schizophrenia-spectrum diagnosis, Chi2(2)=9.79, p<.01. The at-risk groups reported more frequent and severe psychotic-like experiences relative to the control group. These findings support the predictive validity of the Chapman psychosis-proneness scales and may enhance the power of early detection efforts. Copyright (c) 2005 APA, all rights reserved.

Entities:  

Mesh:

Year:  2005        PMID: 15709824     DOI: 10.1037/0021-843X.114.1.170

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  84 in total

1.  Schizotypal, schizoid and paranoid characteristics in the biological parents of social anhedonics.

Authors:  Alex S Cohen; Lindsay C Emmerson; Monica C Mann; Courtney B Forbes; Jack J Blanchard
Journal:  Psychiatry Res       Date:  2010-05-08       Impact factor: 3.222

2.  The challenges of fitting an item response theory model to the Social Anhedonia Scale.

Authors:  Steven P Reise; William P Horan; Jack J Blanchard
Journal:  J Pers Assess       Date:  2011-05

3.  Olfaction and schizophrenia clinical risk status: just the facts.

Authors:  Bruce I Turetsky; Vidyulata Kamath; Monica E Calkins; Warrick J Brewer; Stephen J Wood; Christos Pantelis; Larry J Seidman; Dolores Malaspina; Kimberley P Good; Lili C Kopala; Paul J Moberg
Journal:  Schizophr Res       Date:  2012-05-14       Impact factor: 4.939

4.  Rates of avoidant, schizotypal, schizoid and paranoid personality disorders in psychometric high-risk groups at 5-year follow-up.

Authors:  Diane C Gooding; Kathleen A Tallent; Christie W Matts
Journal:  Schizophr Res       Date:  2007-05-31       Impact factor: 4.939

Review 5.  Anhedonia in schizophrenia.

Authors:  Daniel H Wolf
Journal:  Curr Psychiatry Rep       Date:  2006-08       Impact factor: 5.285

Review 6.  Schizotypy--do not worry, it is not all worrisome.

Authors:  Christine Mohr; Gordon Claridge
Journal:  Schizophr Bull       Date:  2015-03       Impact factor: 9.306

Review 7.  Cognition and brain function in schizotypy: a selective review.

Authors:  Ulrich Ettinger; Christine Mohr; Diane C Gooding; Alex S Cohen; Alexander Rapp; Corinna Haenschel; Sohee Park
Journal:  Schizophr Bull       Date:  2015-03       Impact factor: 9.306

Review 8.  Schizotypy: looking back and moving forward.

Authors:  Thomas R Kwapil; Neus Barrantes-Vidal
Journal:  Schizophr Bull       Date:  2014-12-29       Impact factor: 9.306

9.  Coping Strategies Mediate the Effect of Stressful Life Events on Schizotypal Traits and Psychotic Symptoms in 22q11.2 Deletion Syndrome.

Authors:  Marco Armando; Corrado Sandini; Maelle Chambaz; Marie Schaer; Maude Schneider; Stephan Eliez
Journal:  Schizophr Bull       Date:  2018-10-15       Impact factor: 9.306

Review 10.  Affective traits in schizophrenia and schizotypy.

Authors:  William P Horan; Jack J Blanchard; Lee Anna Clark; Michael F Green
Journal:  Schizophr Bull       Date:  2008-07-29       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.